The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Sexually Transmitted Infections (STIs) Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The sexually transmitted infections (stis) market size has witnessed swift expansion in recent years. This market is anticipated to expand from $71.28 billion in 2025 to $79.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.5%. Factors contributing to its historical growth include the increasing prevalence of STIs, restricted availability of early diagnostic instruments, a rise in government-led awareness campaigns, evolving urbanization and lifestyle patterns, and a greater number of patient visits to sexual health clinics.
The market for sexually transmitted infections (STIs) is projected for significant expansion in the coming years, reaching $126.99 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.4%. This anticipated growth during the forecast period can be attributed to several factors, including the increasing adoption of advanced molecular diagnostics, the expansion of at-home STI testing options, greater integration with telemedicine platforms, augmented funding for STI prevention initiatives, and the emergence of AI-assisted diagnostic instruments. Key trends during this period are expected to encompass the advancement of rapid point-of-care STI testing solutions, a surge in the utilization of home-based STI test kits, an increase in vaccine development for STIs, wider adoption of combination diagnostic platforms, and intensified public awareness campaigns focused on STI prevention.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp
Which Major Factors Are Contributing To The Development Of The Sexually Transmitted Infections (STIs) Market?
An increase in government efforts to raise awareness about sexually transmitted infections is anticipated to boost the sexually transmitted infections (STIs) market in the future. Government initiatives are defined as programs or policies established to achieve specific objectives and resolve particular issues. To prevent, control, and treat STIs, governments provide various programs, including funding for public awareness campaigns, vaccines for specific infections, and accessible screening and testing services at no or low cost. For example, in April 2023, Springfield-Greene County Health, a public health department in the US, introduced the Disease Intervention Specialist (DIS) program. This new initiative, a collaboration with the Missouri Department of Health and Senior Services (Missouri DHSS), aims to tackle the growing incidence of STIs in Greene County. The two specialists within the DIS program will concentrate mainly on syphilis and HIV, contacting individuals who test positive, linking them with treatment resources, and assisting in identifying and informing their contacts about potential exposure. Consequently, the rise in government-led programs is set to propel the sexually transmitted infections (STIs) market.
How Is Segment Classification Applied In The Sexually Transmitted Infections (STIs) Market?
The sexually transmitted infections (stis) market covered in this report is segmented –
1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types
2) By Treatment: Antibiotics, Antiviral
3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea
4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis
5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis
What Trends Are Affecting The Sexually Transmitted Infections (STIs) Market Dynamics?
Leading companies in the sexually transmitted diseases (STD) testing market are concentrating on developing advanced solutions, such as syphilis testing kits, to expand access to testing for a broader population. Syphilis testing kits are diagnostic tools used to identify the Treponema pallidum bacteria, which causes syphilis, through blood samples or other bodily fluids for prompt diagnosis and treatment. For example, in August 2023, iHealth Labs Inc., a US-based medical device company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved iHealth CheckMeSafe Home Collection kit allows individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their own residence. Users can mail their samples to the lab using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit offers highly accurate results, with sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are analyzed in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.
Who Are The Major Companies Operating In The Sexually Transmitted Infections (STIs) Market?
Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.
Access The Complete Sexually Transmitted Infections (STIs) Market Report:
What Is The Largest Regional Market In The Sexually Transmitted Infections (STIs) Market?
North America was the largest region in the sexually transmitted infection (STIs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted infections (stis) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Sexually Transmitted Infections (STIs) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=13047&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Infections (STIs) Market 2026, By The Business Research Company
Std Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Chlamydia Infection Diagnostics Global Market Report 2026
Genital Herpes Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model